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A B S T R A C T
Fine-needle aspiration (FNA) biopsy has become a well established technique in the diagnosis, staging, and follow-up
of patients with head and neck lesions. As in lymphoma diagnostics, FNA serves as a screening method in evaluating po-
tentially affected lymph node for open or core biopsy. According to the World Health Organization classification of lym-
phoid neoplasms, today it is important to recognize cell morphology and reveal its phenotype, then combine it with differ-
ent genotypic information and clinical data to provide appropriate therapy. The aim of this study was to assess the
efficacy of FNA and immunocytochemistry based lymphoma diagnostic in head and neck region. We conducted a retro-
spective study during a period of three years where cases with either FNA diagnosis or clinical suspicion of newly recog-
nized or relapsing lymphoma were reviewed. In the study were included patients that were referred to our laboratory
from hematology department, in whom head and neck lymphadenopathia was found and lymph node FNA preceded
other procedures. Two hundred eighty-five aspirations from 248 patients fulfilled study criteria. Adequate specimens
were diagnosed as lymphoma in 100 cases (36%), in 65 male and 35 female patients, 76 in patients with newly discovered
disease and 24 in patients with prior lymphoma diagnosis. Overall sensitivity of FNA specimens in the diagnosis of head
and neck lymphomas was 90%, specificity 88%, predictive value of a positive result 97%, and predictive value of negative
result 61%. Based on our results FNA corroborated with immunophenotyping by immunocytochemistry can be method of
choice in primary lymphoma diagnosis as a method complementary to histopathology in lymphoma diagnostics.
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Introduction
Fine-needle aspiration (FNA) biopsy has become a
well established technique in the diagnosis, staging, and
follow-up of patients with head and neck lesions. Clini-
cians use FNA to provide rapid diagnostic information
regarding palpable masses of lymph nodes, thyroid gland
and salivary glands. Whether it is a palpable or deeply
seated lesion, where ultrasound guidance is necessary,
lymph node FNA has been used for the diagnoses of in-
flammatory and reactive conditions, as well as lympho-
mas and metastases. In general, FNA is a first-line diag-
nostic procedure in evaluating benign from malignant
lesion that requires further diagnostics. As in lymphoma
diagnostics, FNA serves as a screening method in evalu-
ating potentially affected lymph node for open or core bi-
opsy. The role of FNA as a definitive diagnostic proce-
dure in diagnosing lymphoma is somewhat controversial,
although today the accepted World Health Organization
(WHO) classification defines lymphoid diseases with
combination of morphologic, immunologic, genotypic
and molecular features, putting less emphasis on histo-
pathology as a sole determination of lymphoma subtype.
WHO classification recognizes three major categories of
lymphoid neoplasms: B cell neoplasms, T/NK cell neo-
plasms and Hodgkin lymphoma, where B and NK/T cell
lymphomas are further divided into precursor and pe-
ripheral or mature neoplasms1. Although not included in
the WHO classification, terms such as indolent, aggres-
sive and very aggressive lymphomas are commonly used
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in daily practice. They refer to the natural history and bi-
ologic behavior of the lymphoid neoplasms, and treat-
ment strategy is similar for the entities within each
group2,3. Different types of small B-cell lymphomas, nod-
ular lymphocyte predomination Hodgkin lymphoma
(NLPHL) and cutaneous T-cell lymphomas have indolent
clinical course, while diffuse large B-cell lymphomas
(DLBCL), peripheral T-cell lymphomas (PTCL) and clas-
sical Hodgkin lymphoma (cHL) tend to behave aggres-
sively. Burkitt lymphoma (BL) and lymphoblastic lym-
phoma (LBL) are very aggressive lymphomas. Today it is
important to recognize cell morphology and reveal its
phenotype, then combine it with different genotypic in-
formation and clinical data to provide appropriate therapy.
FNA accuracy for lymphoma diagnosis may be im-
proved using ancillary techniques, such as immunocyto-
chemistry or cytogenetic analyses, in addition to aspira-
tion cytomorphology. In our institution, FNA is a first-
-line diagnostic procedure for the initial evaluation of
head and neck lymphadenopathy, while immunocyto-
chemistry is being used on a routine basis. We speculated
that analysis of FNA specimens coupled with detailed
immunophenotypic analysis might enable us to reliably
distinguish different lymphoma types. The aim of this
study was to assess the efficacy of FNA in that region and
to evaluate its sensitivity regarding lymphoma diagnostics.
Patients and Methods
Study design
We conducted a retrospective study during a period of
three years (from January 2005 until December 2007),
where cases with either FNA diagnosis or clinical suspi-
cion of newly recognized or relapsing lymphoma were re-
viewed. In the study were included patients, regardless
of gender and age that were referred to our laboratory
from hematology department, in whom head and neck
lymphadenopathia was found and lymph node FNA pre-
ceded other procedures. Patients with newly recognized
lymphoma underwent surgical biopsy and histopatho-
logic examination of the same lymph node site within a
time interval of 1 month. Patients with prior diagnosis of
lymphoma were biopsied in the same period of time in
cases where last cytotoxic treatment ended at least 6
months ago. Patients with FNA diagnosis of reactive
lymphoid hyperplasia were generally not biopsied, except
in cases in which the clinical suspicion remained strong
despite a negative cytomorphologic finding.
FNA
All FNAs were performed at least twice on each node
with a 22 Gauge needle and 10 ml plastic syringe using
the reverse Y method (as described by Zajicek)4. Smears
were air dried, part of them were stained with the May-
-Grünwald-Giemsa (MGG) stain using the standard me-
thod. Residual smears were put aside and fixed in cold
acetone (4 °C) for further immunocytochemical analyses.
Smears were evaluated for following features: cell size,
chromatin pattern, nuclear membrane irregularities, pre
sence and shape of nucleoli, presence of mitotic figures
and homogeneity of cell population. Four experienced
cytomorphologists performed aspirations and analyzed
each smear. In dubious cases consensus diagnosis was
reached if three out of four cytomorphologists agreed.
Immunocytochemistry
In cases diagnosed on MGG stained smears as newly
discovered lymphoma, in order to subtype individual
cases, immunocytochemical stainings were performed
with alkaline phosphatase labeled avidin-biotin method
(LSAB+System-AP, DakoCytomation, Glostrup, Den-
mark), according to the protocol described by Dako5. The
primary panel consisted of antibodies against CD3, CD20,
and CD43. Depending on positive reactions and cell mor-
phology, further analyses were performed. If B-cell lym-
phoma was suspected antibodies against CD5, CD10,
CD19, CD23, BCL2, BCL6 and BCL1 were used. In cases
with suspected T-cell lymphoma CD2, CD7, and CD4/
CD8 were used. If Hodgkin’s lymphoma or anaplastic
T-cell lymphoma (ALCL) were suspected, the panel of an-
tibodies consisted of anti- CD15, CD30, CD45, CD20,
EMA and ALK (DakoCytomation, Glostrup, Denmark)
to differentiate between classical Hodgkin’s lymphoma
(cHL), nodular lymphocyte predomination Hodgkin lym-
phoma (NLPHL) and ALCL. If lymphoblastic lymphoma
(LBL) was suspected the antibody against TdT was
added6. Results were evaluated semi-quantitatively, esti-
mating percentage of cells staining positively with a
given marker. The reaction was considered positive if
75% of cells were reactive with given antibody, partially
positive if 25–75% of cells were reactive, and negative if
less than 25% were stained with the antibody. Lym-
phomas were classified based on the WHO classification.
No distinction was made between follicular lymphoma
grade 1, 2 and 3A7. We differentiated NLPHL and cHL,
without subclassification of its subtypes. The cytomor-
phological diagnosis of lymphoma and classification were
established by cytomorphologists unaware of the histo-
pathological diagnosis.
Histopathology
The lymph node biopsies were processed routinely
with hematoxylin and eosin. Immunohistochemistry was
performed on 4-mm-thick deparaffinized tissue sections
using a streptavidin-biotin peroxidase method with anti-
bodies against CD20, CD3, CD15, CD30, CD43,
CD45RO, CD68, EMA, ALK1, TdT (DakoCytomation,
Glostrup, Denmark), CD2, CD4, CD5, CD7, CD8, CD10
(Novocastra, Newcastle, Great Britain). Diagnoses were
made by experienced hematopathologists.
Statistics
FNA specimens were classified as diagnostic of lym-
phoma, negative of lymphoma, and inadequate speci-
mens. Sensitivity, specificity and predictive values were
calculated according to standard methods.
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Ethics
Before undergoing FNA, patients gave informed con-
sent. This study was approved by the Ethical Committee
of the School of Medicine, University of Zagreb.
Results
Between January 2005 and December 2007 we per-
formed 924 lymph node aspirates. Two hundred eighty-
-five aspirations from 248 patients fulfilled study crite-
ria. There were 128 men and 120 women, whose age
ranged from 9 months to 95 years (median 44 years). In
37 patients ultra-sound guided aspiration was perfor-
med. FNA yielded adequate material in 277 of the 285
specimens (97%). Specimens that were inadequate for di-
agnosis consisted of peripheral blood or fragments of
fibroadipose tissue. Adequate specimens were diagnosed
as lymphoma in 100 cases (36%), in 65 male and 35 fe-
male patients, 76 in patients with newly discovered dis-
ease and 24 in patients with prior lymphoma diagnosis.
Specimens diagnosed as benign changes (176 cases,
63%), were interpreted as reactive changes in 164 cases,
granulomatous inflammatory processes in 9 cases, and
changes consistent with necrosis in 3 cases. One speci-
men was interpreted as metastatic seminoma. Immuno-
cytochemical analyses were performed in 73 cases of
newly diagnosed lymphomas, and gave technically satis-
factory result in 67 cases (91%). The cytomorphologic
subclassification of the lymphoma specimens is given in
Table 1. Overall sensitivity of FNA specimens in the di-
agnosis of head and neck lymphomas was 90%, specificity
88%, predictive value of a positive result 97%, and predic-
tive value of a negative result 61%.
Comparison with biopsy specimens
Biopsy specimen from the same lymph node site was
available for comparison purposes in 62 cases. Core bi-
opsy was performed in two cases and open biopsy in the
rest of the cases. Both methods gave the same diagnoses
in 56 out of 62 cases (90%). Lymphoma was present in 53
out of 62 biopsy specimens, benign changes in 8 speci-
mens, and metastatic seminoma in one specimen. Ma-
tching FNA specimens were diagnosed as lymphoma in
48 cases (88%), benign changes in 7 cases, metastatic dis-
ease in one case, while three cases were non-diagnostic
due to material inadequacy (Table 2). There was one
false positive case, where FNA specimen diagnosed as
undifferentiated B-cell lymphoma (B-UCL) proved to be
reactive lymphoid hyperplasia on biopsy specimen. Two
false negative cases that were diagnosed as benign chan-
ges, proved to be follicular lymphoma (FL) on biopsy
specimen. Two out of three inadequate FNA specimens
were diagnosed as Hodgkin's lymphoma on biopsy mate-
rial, and one as diffuse large B-cell lymphoma (DLBCL).
Exact diagnostic agreement was found in diagnosing be-
nign changes, as well as in diagnosing metastatic disease.
Accuracy of lymphoma subclassification
Diagnostic agreement of concurrent FNA and biopsy
specimens in both lymphoma diagnosis and subclassifica-
tion was found in 40 (75%) cases (Tables 3, 4 and 5). Di-
agnosis but not lymphoma subclassification was ren-
dered in 8 cases, mostly among small B-cell lymphomas,
where 5 of histologically proven nodal marginal zone
lymphomas (NMZL) were falsely diagnosed as FL (2
cases), B-UCL (2 cases) and lymphoplasmacytic lym-
phoma (LPL). One histologically diagnosed follicular lym-
phoma was on FNA specimen diagnosed as DLBCL. Two
histologically diagnosed angioimmunoblastic T-cell lym-
phomas (T-AIL) were on FNA specimens diagnosed as
two cases of PTCL, not otherwise specified (PTCL, NOS).
Major diagnostic discrepancy was found in 5 cases, two
patients underwent biopsy despite negative cytomorpho-
logic findings, and were later diagnosed as follicular lym-
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TABLE 1
CYTOMORPHOLOGIC SUBCLASSIFICATION OF LYMPHOMA
SPECIMENS




























SLL – small lymphocytic lymphoma/chronic lymphocyte leuke-
mia, FL – follicular lymphoma, LPL – lymphoplasmacytic lym-
phoma, NMZL – nodal marginal zone lymphoma, DLBCL – dif-
fuse large B-cell lymphoma, BL – Burkitt lymphoma, BUCL –
undifferentiated B-cell lymphoma, PTCL, NOS – peripheral T-
-cell lymphoma, MF – mycosis fungoides, TLBT – lymphoblastic
T-cell lymphoma, ALCL – anaplastic large cell lymphoma, not
otherwise specified, cHL – classical Hodgkin lymphoma, NLPHL
– nodular lymphocyte predomination Hodgkin lymphoma
* histopathologically diagnosed as undifferentiated B-cell lym-
phoma of low malignancy
TABLE 2





Lymphoma 53 48 2 3
Benign changes 8 1 7 0
Other malignancy 1 1 0 0
phomas. In three specimens that were inadequate for
analysis fragments of fibrous tissue were found. One was
histologically diagnosed as DLBCL, and the other two as
Hodgkin's lymphoma. One specimen was falsely diag-
nosed as FL but proved to be benign on biopsy.
Discussion
In the current practice of medicine, which is both
cost-conservative and minimally invasive, FNA serves as
an excellent preliminary diagnostic measure in the eval-
uation of patients with lymphadenopathy. Question re-
mains, could it be used as an alternative morphologic
method in lymphoma diagnostics, as a part of general
evaluation of lymphoma patients that includes cytogene-
tic, molecular and clinical findings. Although histologic
evaluation of affected lymph node has documented ad-
vantages for the lymphoma classification, sometimes it
differentiated from biologic and clinical behavior of the
lymphoma. According to widely accepted WHO classifica-
tion, it is more important to identify the cell morphology
and immunophenotype, along with genetic and clinical
features, than to diagnose lymphoma by pattern of lym-
phoma cell growth.
Approximately one fourth (27%) of patients that came
to our laboratory with lymphadenopathia had enlarged
lymph node in head and neck region, where clinical as-
sessment of masses is highly challenging owing to the
complex anatomy of this region. In 37 cases with deeply
seated lesions, FNA was ultra-sound guided. The sensi-
tivity of FNA for the diagnosis of lymphoma has been re-
ported to range between 66% and 95%8–12. In compari-
son, our diagnostic sensitivity was 90% with predictive
value of positive tests of 97%, and specificity of 88%. Pre-
dictive value of negative tests was rather low, yielded
61%, mostly due to specimen inadequacy which proved to
be major diagnostic limitation of FNA lymphoma diag-
nostics. In some cases, the inherent characteristics of
lymphoma (i.e. fibrosis in cHD) prevent cytomorpho-
logists from obtaining enough material for several analy-
ses. Two of our non-diagnostic specimens due to speci-
men inadequacy were histologically diagnosed as cHL.
Therefore, in the presence of a clinically suspicious
lymph node an aspirate with scant cellularity is a signifi-
cant finding, and demands further investigation (usually
surgical biopsy). Thus results like that can be diagnosed
as suspected lymphoma. Excluding inadequate FNA non-
diagnostic specimens diagnostic sensitivity raises to 96%,
and predictive value of negative tests to 80%. Two cases
of FL were diagnosed as negative of lymphoma. Review
of the clinical data showed that patients were present
with lymph node conglomerates, which may contain re-
active lymph nodes as well as those with lymphoma.
Since aspiration was not ultrasound guided in those pa-
tients, specimen from reactive lymph node was probably
obtained. Although we observed no significant difference
in obtaining adequate specimen between palpation- and
ultrasound-guided FNA, visualizing lymph node changes
may help to choose the right aspiration area and over-
come problems with partial fibrotic changes in affected
lymph node.
Based on a cytomorphology and immunophenotyping
by flow cytometry (FC) recent reports suggest that 63%
to 77% cases can be correctly subclassified according to
WHO classification when compared with histopathology
diagnoses13–15. Simsir et al. reported that in 78 FNA spec-
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TABLE 3
ACCURACY OF FNA BASED LYMPHOMA SUBCLASSIFICATION





EA(%) D FP FN
SLL 5 5 0 0 0
FCC 9 7 1 1 1
NMZL 7 2 5 0 0
DLBCL 11 9 1 0 1
BL 1 1 0 0 0
BUCL 2 2 0 0 0
Total 35 26(73) 7 1 2
SLL – small lymphocytic lymphoma/chronic lymphocyte leuke-
mia, FL – follicular lymphoma, NMZL – nodal marginal zone
lymphoma, DLBCL – diffuse large B-cell lymphoma, BL – Bur-
kitt lymphoma, BUCL – undifferentiated B-cell lymphoma, EA –
exact agreement, D – disagreement, FP-false positive, FN – false
negative
TABLE 4
ACCURACY OF FNA BASED LYMPHOMA SUBCLASSIFICATION





EA(%) D FP FN
cHL 11 7 2 0 2
NLPHL 2 2 0 0 0
Total 13 9(84) 2 0 2
cHL – classical Hodgkin lymphoma, NLPHL – nodular lympho-
cyte predomination Hodgkin lymphoma, EA – exact agreement,
D – disagreement, FP – false positive, FN – false negative
TABLE 5
ACCURACY OF FNA BASED LYMPHOMA SUBCLASSIFICATION





EA(%) D FP FN
TLBL 2 2 0 0 0
TAIL 2 0 2 0 0
ALCL 1 1 0 0 0
Total 5 3(60) 2 0 0
TLBL – lymphoblastic T-cell lymphoma, TAIL – angioimmuno-
blastic T-cell lymphoma, ALCL – anaplastic large cell lympho-
ma, EA – exact agreement, D – disagreement, FP – false posi-
tive, FN – false negative
imen and 28 effusions that were submitted for immuno-
phenotyping because of clinical suspicion of lymphoma,
in 85% of specimen both immunocytochemistry and flow
cytometry was performed and results correlated in 98%
of cases16. We used immunocytochemistry for immuno-
typing which has the advantage of preserving cellular
morphology. When only few atypical cells among a mixed
cellular infiltrate are present, like in T-cell lymphomas or
in cases of necrosis, the possibility to visualize positive
cells may enable diagnosis. A potential pitfall in diagnos-
ing DLBCL by FCmight be lack of light chain restriction.
Analyzing FNA specimen may lead to diagnosis in those
cases. Also, judicious use of antibodies may overcome the
relative scarceness of material and help cytomorpho-
logists to make the proper diagnosis in cases where mate-
rial is not abundant enough for FC to administer appro-
priate battery of antibodies. As in other studies, the
majority of cases in our study comprised of mature B-cell
neoplasms, mostly FL and DLBCL, followed by cHL,
while lymphoid neoplasms of T-cell type were relatively
uncommon. We also obsereved male predominance (male
to female ratio 1,8:1), except in cases with cHL, where ra-
tio was 1,1:1, probably due to the fact that cHL of nodu-
lar sclerosis type, as one of the commonest types of cHL,
ussualy affects young females17,1. Chhieng et al. reported
85% correlation rate between cytomorphology and histo-
pathology in diagnosing B-cell lymphomas with predomi-
nantly small cells, compared with histopathology, and
Zeppa et al. reported that subclassification of small and
medium sized B-cell lymphoma showed 63% sensitivi-
ty18,12. Our results showed exact agreement in both FNA
and histopathology diagnoses in subclassification of no-
dal B-cell lymphomas in 73% of cases. The accuracy var-
ied among subtypes. Lymphoma subtypes with charac-
teristic cytomorphology and specific immunophenotype,
such as small lymphocytic lymphoma (SLL), LPL, and
BL were diagnosed and subclassified with high accuracy.
NMZL and FL have cytomorphologic features that over-
lap with benign processes. Since cell morphology of
NMZL overlap also with other small cell lymphoma sub-
types, especially with FL and LPL, it is not unusual to
misdiagnose it, as we did in our cases. Surface marker
analyses are not helpful in cases of NMZL (they might
just be CD20 positive), so diagnosis is made by exclusion.
These were minor discrepancies occurring in the group
of indolent lymphomas that had no impact on the treat-
ment strategy. Since surface markers diagnostic of a
monoclonal T-cell proliferation have not yet been found,
cytomorphologic findings of a polymorphous pattern and
atypical lymphocytes with convoluted nuclei strongly
suggest lymphoma, especially if they express one domi-
nant T-cell phenotype. As Al Shauqeety et al. and Mayall
et al. agreed in their reports, diagnosis of peripheral
T-cell lymphomas can be achieved by FNA in the major-
ity of cases through close analysis of the cytomorpholo-
gy19,20. Yao et al. had 77% correlation with histopathology
results analyzing 33 cases of various peripheral T-cell
lymphomas21. We had a total of just 5 cases of histolo-
gically proved T-cell lymphomas. Two cases had initial
FNA diagnosis of PTCL, NOS, two of LBL and one of
ALCL, but exact diagnostic agreement was obtained in
60% of cases. However, this is of no clinical significance,
since the treatment approach is similar for these cases.
As in the other studies where FNA diagnosis of Hodgkin
lymphoma was evaluated, we did not differ between sub-
types of cHL because it has less impact on the manage-
ment and prognosis. We differentiated NLPHL because
it is a CD20 positive entity which has slow disease course
and an excellent prognosis compared with the other sub-
types of cHL. Specimen inadequacy is the major problem
in diagnosing cHL, since nodular sclerosis accounts for
approximately 70% of cHL. It is characterized with fib-
rosing process and thickening of a lymph node capsule,
so aspiration may be insufficient to produce enough ma-
terial to analyze. Inadequate specimens comprised 15%
of our cHL specimens, yet the agreement between cyto-
morphology and histopathology was 84%. Chhieng et al.
reported 11% of specimens as non-diagnostic due to
inadequte cellularity, and Friedman et al. 23%22,23. Zhang
et al. proposed on-site evaluation of specimen adequacy
and specimen triage24. As we already pointed out, sam-
pling error, as major cause of specimen inadequacy, may
be minimized by image guidance using ultrasound, and
in our opinion every patient with clinical suspicion of
Hodgkin lymphoma has to be aspirated under ultra-
sound guidance.
Conclusion
In summary, FNA based lymphoma diagnosis will re-
main challenge for cytomorphologists, in trying to evade
possible pitfalls of the method. FNA based diagnosis can
not replace histopathologic diagnosis, because there will
always be cases impossible to diagnose on smears only
(i.e. composite lymphoma, panniculitis like T-cell lym-
phoma, extensive fibrosis of lymph node in nodular scle-
rosis subtype of cHL). Based on our results, sensitivity of
90% and specificity of 88%, FNA corroborated with im-
munophenotyping by immunocytochemistry can be me-
thod of choice in primary lymphoma diagnosis, and not
just in cases where affected lymph nodes are deeply
seated as intraabdominal or intrathoracic masses, or pa-
tient is to risky surgical candidate, or clinical course is so
malignant that there is no time left for surgical biopsy.
Although based on a small number of cases, in our opin-
ion nodal lymphomas with distinct cytomorphologic cha-
racteristics, such as SLL, LPL, mantle cell lymphoma
(MCL), BL, DLBCL, LBL, ALCL, NLPHL and cHL can
be accurately diagnosed by FNA. In cases of FL grades
1–3, NMZL, PTCL, TAIL and some cases of cHL further
diagnostic procedures are necessary. FNA can routinely
provide samples that are adequate for molecular analy-
ses, which can be helpful in diagnosis of selected lym-
phoma subtypes (i.e. t(14;18) is present in approximately
80% of FL, t(11;14) is useful in distinguishing NMZL, in
situ hybridization for Epstein-Barr virus can serve as a
marker in diagnosis of T-AIL)25–27. FNA offers prelimi-
nary diagnosis in the investigation of patients with lym-
phadenopathy, as a procedure causing minimal trauma
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to the patient. When aspirations is performed with expe-
rienced operator using ultrasound guidance, lymph
nodes that are appropriate for sufficient material aspira-
tion may be visualized, which can lower numbers of neg-
ative diagnoses. Furthermore, additional usage of cytoge-
netics and molecular techniques, together with immu-
nocytochemistry makes cytomorphology valuable diag-
nostic tool in lymphoma diagnostics enabling it to be
used as a method complementary to histopathology.
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CITOMORFOLO[KA DIJAGNOZA LIMFOMA U PODRU^JU GLAVE I VRATA
S A @ E T A K
Citomorfolo{ka analiza uzorka dobivenog punkcijom tankom iglom neizostavna je metoda u dijagnostici i pra}enju
lije~enja promjena u podru~ju glave i vrata. U dijagnostici limfoma citomorfolo{ka analiza uzorka slu`i kao metoda
probira za odabir zahva}enog ~vora za otvorenu ili biopsiju {irokom iglom. Prema Klasifikaciji limfoidnih novotvorina
Svjetske zdravstvene organizacije danas je potrebno prepoznati stani~nu morfologiju, te uz nalaze imunofenotipizacije i
geneti~kih analiza, kao i klini~kih pokazatelja odlu~iti o terapiji odgovaraju}oj za pojedinog bolesnika. Cilj ove studije
bio je utvrditi u~inkovitost citomorfolo{ke i imunocitokemijske analize u dijagnostici limfoma u podru~ju glave i vrata.
U retrospektivnom istra`ivanju pregledali smo sve slu~ajeve tijekom trogodi{njeg perioda, sa citomorfolo{kom dijagno-
zom ili klini~kom sumnjom na novootkriveni limfom ili relapsom ve} postoje}e bolesti. U studiju su bili uklju~eni pa-
cijenti upu}eni u na{u ambulantu od hematologa, sa pove}anim limfnim ~vorom u podru~ju glave i vrata, kojima je
citomorfolo{ka analiza prethodila ostalim dijagnosti~kim postupcima. U~injeno je 285 aspiracijskih punkcija u 248 pa-
cijenata koji su ispunili uvjete za studiju. Uzorci adekvatni za citomorfolo{ku analizu dijagnositicirani su kao limfom u
100 slu~ajeva (36%), kod 65 pacijenata i 35 pacijentica, 76 kod pacijenata sa novo-otkrivenom bole{}u, 24 kod bolesnika
s prija{njom dijagnozom limfoma. Osjetljivost citomorfolo{ke analize u dijagnostici limfoma u podru~ju glave i vrata
iznosila je 90%, specifi~nost 88%, prediktivna vrijednost pozitivnog testa 97%, prediktivna vrijednost negativnog testa
61%. Prema na{im rezultatima citomorfolo{ka analiza, upotpunjena imunocitokemijskim odre|ivanjem limfati~nih
biljega mo`e postati metoda izbora u primarnoj dijagnostici limfoma, kao metoda komplementarna patohistolo{koj
analizi.
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